Sign In
Get Clay Free →

Suggestions

    Mindaugas Zagorskis

    Founder and CEO at Pipelinepharma

    Mindaugas Zagorskis is a prominent figure in the pharmaceutical industry, serving as the Co-Founder and CEO of Pipelinepharma since March 2012.1 He is based in Vilnius, Lithuania, and has established himself as a visionary leader in the field.1

    Professional Background

    Zagorskis founded Pipelinepharma, a B2B marketplace for the pharmaceutical industry that connects manufacturers with distributors globally.1 The platform facilitates the discovery of qualified distributors, the signing of licensing and supply agreements, and market expansion for pharmaceutical companies.1

    Career History

    Before his current role, Zagorskis held several positions in the pharmaceutical and healthcare sectors:

    • Private Investor at Cardinity (2014-2022)
    • General Manager at Orivas (2007-2012)
    • Business Development Manager at PharmaSwiss (2004-2006)
    • Sales and Marketing Manager at Pfizer (2003-2004)
    • Managing Director at KEN Hygiene Systems a/s (2000-2003)
    • Medical Representative at Organon (1999-2000)1

    Education

    Zagorskis has a strong educational background in both medicine and business:

    • Doctor of Medicine from Lithuanian University of Health Sciences (1992-1999)
    • Master of Business Administration (MBA) from Vilnius University Business School (1999-2003)
    • Board Member certification from Baltic Institute of Corporate Governance (2016)1

    Language Skills

    He is proficient in multiple languages:

    • Russian (professional working proficiency)
    • English (professional working proficiency)
    • Lithuanian (native or bilingual proficiency)1

    Mindaugas Zagorskis continues to be active in the pharmaceutical industry, frequently sharing updates and insights about pharmaceutical licensing, CTD dossiers, and GMP manufacturers through his LinkedIn profile.234

    Related Questions

    What inspired Mindaugas Zagorskis to start Pipelinepharma?
    How has Pipelinepharma evolved since its founding in 2012?
    What are some key achievements of Mindaugas Zagorskis in his career?
    How does Pipelinepharma benefit small and medium-sized pharmaceutical companies?
    What challenges has Mindaugas Zagorskis faced as CEO of Pipelinepharma?